Last updated: August 3, 2023
Sponsor: Institut de Cancérologie de Lorraine
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer
Diabetes Prevention
Treatment
N/AClinical Study ID
NCT03919149
2018-08Obs-CHRMT
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Major patient
- With an histollogically confirmed non-metastatic (breast, prostate or colorectal)cancer diagnosis
- To be addressed to an oncologist before the beginning of any treatment
- Informed and having agreed to participate in the study
- Operated patient without adjuvant therapy
Exclusion
Exclusion Criteria:
- Presence of threatening bone lesion
- physical, cognitive or linguistics incapacity to fulfil the questionnaire
- With a life expectancy of less than 6 months
- Pregnant woman
- Under legal protection or deprived of liberty
Study Design
Total Participants: 693
Study Start date:
October 09, 2019
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
CHR Metz Thionville
Metz,
FranceActive - Recruiting
Institut de Cancérologie de Lorraine
Nancy,
FranceActive - Recruiting
CHR Metz Thionville
Thionville,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.